IMVAMUNE® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Phase I Trial of an Investigational Small Pox Medication
A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
SIGA-246 to Treat Smallpox
† Study has passed its completion date and status has not been verified in more than two years.